5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Roaring to a record Stocks are on a tear heading into the last full …
Pfizer Inc
2024 expectations for Wegovy, Ozempic, Zepbound
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed …
Is Novo Nordisk a buy? Wall Street banks weigh in
For many investors, the weight loss drug boom has boosted Danish pharmaceutical giant Novo Nordisk ‘s appeal this year — but one investment bank has reservations. “Over the coming year, …
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to …
Pfizer 2024 revenue, profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also raised …
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 1, 2023. Brendan Mcdermid | Reuters U.S. stock futures ticked higher Wednesday …
Biden administration asserts power to seize drug patents
President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. …
The pros weigh in on weight-loss stocks
It has been quite a year for both Eli Lilly and Novo Nordisk given the boom in weight-loss drugs. Stocks of both pharmaceutical companies have rallied this year. Shares in …
Free ChatGPT may incorrectly answer drug questions, study says
Harun Ozalp | Anadolu | Getty Images The free version of ChatGPT may provide inaccurate or incomplete responses — or no answer at all — to questions related to medications, …
Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain …